Fabrinet
2 nominees · 3 ballot items.
The proxy statement presents three matters for a vote: Proposal 1 election of two Class I directors for a three-year term; Proposal 2 ratification of the appointment of PricewaterhouseCoopers ABAS Ltd. as Fabrinet’s independent registered public accounting firm for the fiscal year ending June 26, 2026; and Proposal 3 advisory vote to approve named executive officer compensation.
Follow how the vote landed and what changed on Fabrinet’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot3
- 1
Election of two Class I directors
ManagementBoard: FORElection of two Class I director nominees to serve for a three-year term expiring in 2028.
- 2
Ratification of the appointment of independent registered public accounting firm
ManagementBoard: FORRatification of PricewaterhouseCoopers ABAS Ltd. as Fabrinet’s independent registered public accounting firm for the fiscal year ending June 26, 2026.
- 3
Advisory vote to approve named executive officer compensation
ManagementBoard: FORAdvisory vote to approve compensation of Fabrinet's named executive officers as disclosed in this proxy statement.
Nominees on the ballot2
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | PRICE T ROWE ASSOCIATES INC /MD/ | 10.6% | 3,799,025 | $2.0B |
| 2 | BlackRock, Inc. | 9.4% | 3,375,871 | $1.8B |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 6.0% | 2,134,154 | $1.1B |
| 4 | FMR LLC | 4.8% | 1,706,640 | $890M |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 4.5% | 1,606,981 | $838M |
| 6 | STATE STREET CORP | 3.6% | 1,300,008 | $678M |
| 7 | BlackRock, Inc. | 3.5% | 1,236,611 | $645M |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 3.0% | 1,068,009 | $560M |
| 9 | Invesco Ltd. | 2.0% | 714,541 | $373M |
| 10 | WASATCH ADVISORS LP | 2.0% | 703,140 | $367M |
Other Technology sector meetings6
Upcoming shareholder meetings at Fabrinet’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Fabrinet 2025 annual meeting?
- Fabrinet (FN) holds its 2025 annual shareholder meeting on Thursday, December 11, 2025.
- What is the record date for the Fabrinet 2025 meeting?
- The record date for the Fabrinet 2025 meeting is Thursday, October 16, 2025. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Fabrinet's 2025 meeting?
- The board is presenting 2 director nominees at the Fabrinet 2025 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Fabrinet 2025 meeting?
- Shareholders will vote on 3 proposals at the Fabrinet 2025 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.